Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers

INTRODUCTION: Lesinurad is a selective uric acid reabsorption inhibitor approved for the treatment of gout in combination with a xanthine oxidase inhibitor (XOI) in patients who have not achieved target serum uric acid (sUA) levels with an XOI alone. Most people with gout have chronic kidney disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillen, Michael, Valdez, Shakti, Zhou, Dongmei, Kerr, Bradley, Lee, Caroline A, Shen, Zancong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098526/
https://www.ncbi.nlm.nih.gov/pubmed/27843295
http://dx.doi.org/10.2147/DDDT.S119944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098526/
https://www.ncbi.nlm.nih.gov/pubmed/27843295
http://dx.doi.org/10.2147/DDDT.S119944

Ejemplares similares